儿童白塞病临床表型与长期损害:ISG、ICBD与PEDBD分类标准在地方性队列中的比较性能
该回顾性队列研究纳入土耳其地方性流行区69例临床诊断的儿童白塞病(pBD)患儿,比较ISG、ICBD与PEDBD分类标准的敏感性,并评估器官受累、治疗模式、结局及累积损害。结果显示ICBD分类敏感性达97.1%,显著高于ISG的58.0%和PEDBD的53.6%;神经血管事件及后节眼病是主要致残因素,累积损害以BODI平均0.45分处于低至中等水平。
要点
- ICBD在儿童白塞病中分类敏感性最高(97.1%),ISG与PEDBD仅约半数。
- 神经血管受累占18.8%(以脑静脉血栓为主),后节眼病占11.6%。
- 男孩神经血管病风险更高,女孩生殖器溃疡更常见。
核心结论
- 在地方性儿童白塞病队列中,ICBD分类敏感性优于ISG和PEDBD。
- 疾病致残主要由神经血管事件及后节眼病驱动。
- 建议以ICBD为锚定标准,同时报告ISG和PEDBD以保持可比性。
研究设计与样本
- 回顾性分析土耳其三级中心2020-2025年连续69例临床诊断的儿童白塞病(症状起病≤18岁)。
- 在末次访视时应用ISG(1990)、ICBD(2014)与PEDBD(2016)分类标准。
- 主要结局为分类标准相对临床诊断的敏感性,次要结局包括性别分层风险、治疗/不良事件及累积损害。
主要发现
- ICBD分类97.1%病例,ISG为58.0%,PEDBD为53.6%。
- 神经血管受累18.8%(主要为脑静脉血栓),血管受累20.3%,眼部受累17.4%(后节11.6%)。
- 男孩神经血管病风险更高,女孩生殖器溃疡更常见。
- 治疗包括秋水仙碱98.6%、硫唑嘌呤63.8%、抗肿瘤坏死因子21.7%;不良事件15.9%,不依从11.6%。
- 累积损害低至中等,平均BODI评分0.45(范围0-3)。
关键数值与推荐
- ICBD(2014)分类敏感性97.1%,ISG(1990)58.0%,PEDBD(2016)53.6%。
- 神经血管受累18.8%,血管受累20.3%,眼部受累17.4%,后节眼病11.6%。
- 秋水仙碱使用98.6%,硫唑嘌呤63.8%,抗肿瘤坏死因子21.7%。
- 不良事件15.9%,不依从11.6%。
- 平均BODI评分0.45(范围0-3)。
临床怎么用
- 在儿童白塞病中优先采用ICBD分类以减少漏诊,同时报告ISG/PEDBD便于比较。
- 对疑似神经或眼部受累者行低阈值神经眼科评估,及时升级激素节约治疗。
- 关注男孩神经血管风险及女孩生殖器溃疡表现。
- 对青少年患者加强依从性管理,并针对性进行血管影像学检查。
局限性
- 单中心回顾性设计,样本量69例,结论外推受限。
- 分类标准仅在末次访视时应用,未评估随时间的变化。
- 未报告对照组或非白塞病人群的分类性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the sensitivity of International Study Group (ISG, 1990), International Criteria for Behçet's Disease (ICBD, 2014) and the Paediatric Behçet's Disease (PEDBD, 2016) classification criteria in paediatric Behçet's disease (pBD) within an endemic cohort and to assess organ involvement, treatment patterns, outcomes and cumulative damage using the Behçet's Syndrome Overall Damage Index. METHODS: We retrospectively analysed 69 consecutive children with clinician-diagnosed pBD (symptom onset ≤18 years) at a tertiary centre in Türkiye (2020-2025). Classification criteria were applied at the last visit. The primary outcome was sensitivity versus clinician diagnosis; secondary outcomes included sex-stratified risks, therapies/adverse events and cumulative damage. RESULTS: ICBD classified 97.1% of cases, compared with 58.0% for ISG and 53.6% for PEDBD. Neurovascular involvement occurred in 18.8% (mainly cerebral venous thrombosis), vascular in 20.3% and ocular in 17.4% (posterior-segment 11.6%). Boys had higher risks of neurovascular disease, while girls more often had genital ulcers. Treatment followed steroid-sparing pathways (colchicine 98.6%, azathioprine 63.8%, antitumour necrosis factor 21.7%); adverse events occurred in 15.9% and non-adherence in 11.6%. Cumulative damage was low to moderate, with a mean BODI score of 0.45 (range 0-3). CONCLUSIONS: In this endemic paediatric cohort, ICBD demonstrated superior sensitivity, while ISG and PEDBD classified only half of cases. Morbidity was driven by neurovascular events and, less frequently, posterior-segment ocular disease. Findings support an ICBD-anchored approach with co-reporting of ISG/PEDBD for comparability. Low-threshold neuro-ophthalmic evaluation and timely steroid-sparing escalation are critical for sight/central nervous system-threatening disease. Targeted vascular imaging and adherence-focused adolescent care remain priorities.
引用
- Bozkaya Yücel B, Doğantan Ş, Çelik ÖG, et al. Clinical phenotype and long-term damage in paediatric Behçet's disease: comparative performance of ISG, ICBD and PEDBD classification criteria in a retrospective endemic cohort. RMD Open. 2026. PMID: 41802833. doi:10.1136/rmdopen-2025-006514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。